Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 10Recruiting 5Unknown 4Terminated 3Not yet recruiting 3Active not recruiting 3

Sponsor Class

NETWORK 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 34Squamous Cell Carcinoma of Head and Neck 32Head and Neck Neoplasms 30Urinary Bladder Neoplasms 19Uterine Cervical Neoplasms 18Stomach Neoplasms 17Esophageal Neoplasms 17Small Cell Lung Carcinoma 16Cholangiocarcinoma 16Neoplasm Metastasis 13Ovarian Neoplasms 12Carcinoma, Squamous Cell 11Breast Neoplasms 11Neoplasms 10Mesothelioma, Malignant 9Esophageal Squamous Cell Carcinoma 8Biliary Tract Neoplasms 8Sarcoma 7Fallopian Tube Neoplasms 7Pancreatic Neoplasms 6Mesothelioma 6Adenocarcinoma of Lung 6Adenocarcinoma Of Esophagus 6Recurrence 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Triple Negative Breast Neoplasms 4Osteosarcoma 4

Interventions

pembrolizumab 8Paclitaxel 8Carboplatin 6niraparib 3Megestrol Acetate 3Cisplatin 3tislelizumab 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2rucaparib 2olaparib 2iso-sulfan blue 2copanlisib 2Taxes 2Surveys and Questionnaires 2Nivolumab 2Lymph Node Excision 2Indocyanine Green 2Fulvestrant 2Filgrastim 2Doxorubicin 2Docetaxel 2tremelimumab 1spartalizumab 1sonidegib 1ribociclib 1rebastinib 1pemigatinib 1nicotinamide-beta-riboside 1lenvatinib 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Endometrial Neoplasms × Cisplatin × Clear all
NCT02393248 2023-01-06

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Incyte Corporation

Phase 1/2 Terminated
201 enrolled 71 charts
BreastGastrointestinalGynecologicMyeloidPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Myeloproliferative Disorders, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT00003624 2013-04-11

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

GOG Foundation

Phase 2 Terminated
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Neurotoxicity Syndromes

NCT00016341 2013-04-11

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

GOG Foundation

Phase 3 Terminated
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡